TITLE

'3 by 5' makes progress but falls short

AUTHOR(S)
Roehr, Bob
PUB. DATE
July 2005
SOURCE
Bay Area Reporter;7/7/2005, Vol. 35 Issue 27, p13
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
Reports on the possibility that the goal of the "3 by 5," program aimed at providing antiretroviral therapy to people living with HIV/AIDS in developing countries by the end of 2005 would not be met. Highlights of an interim report by the World Health Organization and UN-AIDS, released on June 29, 2005; Estimated number of people on antiviral therapy when the initiative began.
ACCESSION #
17600349

 

Related Articles

  • Supply of low-cost HIV?AIDS drugs heading for crisis.  // PharmacoEconomics & Outcomes News;11/19/2005, Issue 491, p14 

    The article focuses on a report published in the November 2005 issue of the "British Medical Journal" that World Health Organization director for HIV/AIDS Jim Wong has warned that developing countries will continue to face supply shortage of low-cost antiretroviral HIV/AIDS drugs unless measures...

  • New report highlights progress in universal HIV/AIDS drugs access.  // PharmacoEconomics & Outcomes News;5/5/2007, Issue 527, p10 

    The article reports a growth in access to antiretroviral therapy for advanced human immunodeficiency virus (HIV) infections in low- and middle-income countries. The claim was based on a report published by the World Health Organization, the Joint United Nations Programme on HIV/acquired...

  • Access to HIV treatment continues to accelerate in developing countries, but bottlenecks persist, says WHO/UNAIDS report.  // Indian Journal of Medical Sciences;Jul2005, Vol. 59 Issue 7, p323 

    Focuses on the report released by the World Health Organization (WHO) and the Joint United Nations Program on HIV/AIDS (UNIAIDS), which found that the number of people receiving antiretroviral therapy (ART) for HIV/AIDS in developing countries is increasing significantly. Rate of increase in...

  • Towards universal access: WHO's role in HIV prevention, treatment and care. De Cock, Kevin; Grubb, Ian // Bulletin of the World Health Organization;Jul2006, Vol. 84 Issue 7, p506 

    The article discusses the initiative of the World Health Organization (WHO) to provide treatment to people with HIV/AIDS in developing countries. Through the efforts of the WHO, about 1.3 million people infected with HIV have now received combination antiretroviral therapy in low- and...

  • Steps on the Critical Path: Arresting HIV/AIDS in Developing Countries. Gerberding, Julie // PLoS Medicine;Oct2004, Vol. 1 Issue 1, p014 

    Focuses on HIV/AIDS epidemic in developing countries. Information on the U.S. Centers for Disease Control and Prevention program in Uganda; Administration of antiretroviral drugs to HIV infected individuals in the region; Discussion on funding for AIDS intervention programs in Africa.

  • Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: Has WHO offered a milestone for HIV prevention? Menon, Sonia // Journal of Public Health Policy;2010, Vol. 31 Issue 4, p385 

    The majority of new HIV infections occur in sub-Saharan Africa and other developing countries with scarce financial resources and meagre health system infrastructure. Expansion of Antiretroviral Therapy (ART) may overwhelm health services capacity, result in suboptimal care, and divert attention...

  • Who hopes 3-by-5 plan will reverse Africa's HIV/AIDS epidemic. Fleck, Fiona // Bulletin of the World Health Organization;Jan2004, Vol. 82 Issue 1, p77 

    Reports that the World Health Organization (WHO) that its program called 3-by-5 initiative will reverse Africa's HIV and AIDS epidemic by 2005. Plan to bring antiretroviral treatment to three million people; Statements by WHO Director General Lee Jongwook; Plan to train about 100,000 paramedics...

  • Diseases in the Third World Challenge Manufacturers. Wechsler, Jill // Pharmaceutical Technology;Oct2005, Vol. 29 Issue 10, p36 

    Focuses on challenges in manufacturing fixed-dose combination drugs for AIDS patients in developing countries. Need for expansion of manufacturing operations to meet demands for AIDS drugs; Meeting of worldwide regulatory standards; Problems of Bristol-Myers Squibb in meeting demand for...

  • Scaling-Up Care and Treatment for People Living with HIV and AIDS in the Developing World. Magaziner, Ira // Brown Journal of World Affairs;Summer/Fall2004, Vol. 11 Issue 1, p27 

    Presents information on the treatment for people living with HIV and AIDS in the developing world. Importance of prevention, care and treatment efforts to fight the disease; Aim of the Clinton HIV/AIDS Initiative established in 2002; Obstacles that inhibit the scaling up of effective AIDS...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics